The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced Cancer
Abstract
Purpose: Cancer-related fatigue (CRF) is the most common symptom in patients with advanced cancer. The primary objective of this prospective, randomized, double-blind, placebo-controlled study was to compare the effect of dexamethasone and placebo on CRF. Patients and Methods: Patients with advanced cancer with ≥ three CRF-related symptoms (ie, fatigue, pain, nausea, loss of appetite, depression, anxiety, or sleep disturbance) ≥ 4 of 10 on the Edmonton Symptom Assessment Scale (ESAS) were eligible. Patients were randomly assigned to either dexamethasone 4 mg or placebo orally twice per day for 14 days. The primary end point was change in the Functional Assessment of Chronic Illness–Fatigue (FACIT-F) subscale from baseline to day 15. Secondary outcomes included anorexia, anxiety, depression, and symptom distress scores. Results: A total of 84 patients were evaluable (dexamethasone, 43; placebo, 41). Mean (± standard deviation) improvement in the FACIT-F subscale at day 15 was significantly higher in the dexamethasone than in the placebo group (9 [± 10.3] v 3.1 [± 9.59]; P = .008). The improvement in FACIT-F total quality-of-life scores was also significantly better for the dexamethasone group at day 15 (P = .03). The mean differences in the ESAS physical distress scores at day 15 were significantly better for the dexamethasone group (P = .013, respectively). No differences were observed for ESAS overall symptom distress (P = .22) or psychological distress score (P = .76). Frequency of adverse effects was not significantly different between groups (41 of 62 v 44 of 58; P = .14). Conclusion: Dexamethasone is more effective than placebo in improving CRF and quality of life in patients with advanced cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analysis of variance test for normality (complete samples)
SHAPIRO, S. S., & WILK, M. B. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.591 · Cited by 23,480
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991) · Journal of Palliative Care · doi:10.1177/082585979100700202 · Cited by 2,683
Self-citationCella, D., Eton, D. T., Lai, J.-S., Peterman, A. H., & Merkel, D. E. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00529-8 · Cited by 808
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 608
Mechanisms of Cancer-Related Fatigue
Ryan, J. L., Carroll, J. K., Ryan, E. P., Mustian, K. M., Fiscella, K., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-22 · Cited by 583
Availability and Integration of Palliative Care at US Cancer Centers
Hui, D. (2010) · JAMA · doi:10.1001/jama.2010.258 · Cited by 495
Self-citationConstruct validation of the hospital anxiety and depression scale with clinical populations
Johnston, M., Pollard, B., & Hennessey, P. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00102-1 · Cited by 383
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., Krook, J. E., Wilwerding, M. B., Rowland, K. M., Camoriano, J. K., Novotny, P. J., & Christensen, B. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3299 · Cited by 343
Carroll, B. T., Kathol, R. G., Noyes, R., Wald, T. G., & Clamon, G. H. (1993) · General Hospital Psychiatry · doi:10.1016/0163-8343(93)90099-a · Cited by 331
Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
Loprinzi, C. L., Ellison, N. M., Schaid, D. J., Krook, J. E., Athmann, L. M., Dose, A. M., Mailliard, J. A., Johnson, P. S., Ebbert, L. P., & Geeraerts, L. H. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1127 · Cited by 318
Dalal, S., Palla, S., Hui, D., Nguyen, L., Chacko, R., Li, Z., Fadul, N., Scott, C., Thornton, V., Coldman, B., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0161 · Cited by 296
Self-citationBruera, E., Valero, V., Driver, L., Shen, L., Willey, J., Zhang, T., & Palmer, J. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8506 · Cited by 289
Self-citationDrug therapy for the management of cancer-related fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006704.pub3 · Cited by 283
A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn250 · Cited by 283
Berger, A. M., Abernethy, A. P., Atkinson, A., Barsevick, A. M., Breitbart, W. S., Cella, D., Cimprich, B., Cleeland, C., Eisenberger, M. A., Escalante, C. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0067 · Cited by 280
Symptom clustering in advanced cancer
Walsh, D., & Rybicki, L. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-005-0899-z · Cited by 264
Corticosteroid therapy of preterminal gastrointestinal cancer
Moertel, C. G., Schutt, A. J., Reitemeier, R. J., & Hahn, R. G. (1974) · Cancer · doi:10.1002/1097-0142(197406)33:6<1607::aid-cncr2820330620>3.0.co;2-v · Cited by 258
A Review of the Reliability and Validity of the Edmonton Symptom Assessment System
Richardson, L. A., & Jones, G. W. (2009) · Current Oncology · doi:10.3747/co.v16i1.261 · Cited by 258
Pharmacological treatments for fatigue associated with palliative care
Mücke, M., Mochamat, M., Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788.pub3 · Cited by 227
Loprinzi, C. L., Michalak, J. C., Schaid, D. J., Mailliard, J. A., Athmann, L. M., Goldberg, R. M., Tschetter, L. K., Hatfield, A. K., & Morton, R. F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.762 · Cited by 223
Bruera, E., Driver, L., Barnes, E. A., Willey, J., Shen, L., Palmer, J. L., & Escalante, C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.156 · Cited by 206
Self-citationFatigue is the most important symptom for advanced cancer patients who have had chemotherapy
Butt, Z., Rosenbloom, S. K., Abernethy, A. P., Beaumont, J. L., Paul, D., Hampton, D., Jacobsen, P. B., Syrjala, K. L., Von Roenn, J. H., & Cella, D. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0036 · Cited by 195
Goldberg, R. M., Loprinzi, C. L., Mailliard, J. A., O'Fallon, J. R., Krook, J. E., Ghosh, C., Hestorff, R. D., Chong, S. F., Reuter, N. F., & Shanahan, T. G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2856 · Cited by 184
Prednisolone as an appetite stimulant in patients with cancer.
Willox, J. C., Corr, J., Shaw, J., Richardson, M., Calman, K. C., & Drennan, M. (1984) · BMJ · doi:10.1136/bmj.288.6410.27 · Cited by 180
Osta, B. E., Palmer, J. L., Paraskevopoulos, T., Pei, B.-L., Roberts, L. E., Poulter, V. A., Chacko, R., & Bruera, E. (2008) · Journal of Palliative Medicine · doi:10.1089/jpm.2007.0103 · Cited by 177
Self-citationPain, Depression, and Fatigue as a Symptom Cluster in Advanced Cancer
Laird, B. J. A., Scott, A. C., Colvin, L. A., McKeon, A.-L., Murray, G. D., Fearon, K. C. H., & Fallon, M. T. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.10.261 · Cited by 170
Yennurajalingam, S., Urbauer, D. L., Casper, K. L. B., Reyes-Gibby, C. C., Chacko, R., Poulter, V., & Bruera, E. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.03.017 · Cited by 168
Self-citationMetz, C. A., Robustelli Della Cuna, G., Pellegrini, A., & Piazzi, M. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90353-2 · Cited by 162
Multidimensional independent predictors of cancer-related fatigue
Hwang, S. S., Chang, V. T.-S., Rué, M., & Kasimis, B. S. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00218-5 · Cited by 140
Cheung, W. Y., Barmala, N., Zarinehbaf, S., Rodin, G., Le, L. W., & Zimmermann, C. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2008.03.008 · Cited by 128
Carvajal, A., Centeno, C., Watson, R. A., & Bruera, E. D. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.027 · Cited by 115
Self-citationDonepezil for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial
Bruera, E. D., Osta, B. E. E., Valero, V., Driver, L., Pei, B.-L., Shen, L. F., Poulter, V. A., & Palmer, J. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9231 · Cited by 114
Self-citationThe use of corticosteroids in home palliative care
Mercadante, S., Fulfaro, F., & Casuccio, A. (2001) · Supportive Care in Cancer · doi:10.1007/s005200000218 · Cited by 102
Bruera, E. D., Ernst, S., Hagen, N. A., Spachynski, K., Belzile, M., Hanson, J., Summers, N., Brown, B. A., Dulude, H., & Gallant, G. (1998) · PubMed · Cited by 99
Self-citationThe use of corticosteroids in the treatment of symptoms associated with cancer
Ettinger, A. B., & Portenoy, R. K. (1988) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(88)90167-4 · Cited by 94
Palliative Management of Fatigue at the Close of Life: “It Feels Like My Body Is Just Worn Out”
Yennurajalingam, S., & Bruera, E. D. (2007) · JAMA · doi:10.1001/jama.297.3.295 · Cited by 84
Self-citationAssociation between fatigue and other cancer-related symptoms in patients with advanced cancer
Yennurajalingam, S., Palmer, J. L., Zhang, T., Poulter, V. A., & Bruera, E. D. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0466-5 · Cited by 78
Self-citationCorticosteroids in advanced cancer.
Twycross, R. (1992) · BMJ · doi:10.1136/bmj.305.6860.969 · Cited by 41
Fatigue symptom clusters—A reality or myth?
Yennurajalingam, S., Urbaeur, D., Chacko, R., Busby, K., Poulter, V. A., & Bruera, E. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.20564 · Cited by 4
Self-citationLong term survivors of childhood brain cancer have an increased risk for cardiovascular disease
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9
Cited by
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Arbour, K. C., Mezquita, L., Long, N., Rizvi, H., Auclin, E., Ni, A., Martínez-Bernal, G., Ferrara, R., Lai, W. V., Hendriks, L. E. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.0006 · Cited by 1,071
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
The Edmonton Symptom Assessment System 25 years later: past, present, and future developments
Hui, D., & Bruera, E. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.10.370 · Cited by 795
Self-citation
Metadata
- Authors
- Yennurajalingam, S., Frisbee-Hume, S., Palmer, J. L., Delgado-Guay, M. O., Bull, J., Phan, A. T., Tannir, N. M., Litton, J. K., Reddy, A., Hui, D., Dalal, S., Massie, L., Reddy, S. K., & Bruera, E.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-09-01
- Volume
- 31
- Issue
- 25
- Pages
- 3076-3082
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2137586470
- Cited by
- 348
- References
- 41
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.